NASDAQ:CHTP (CHTP) (CHTP) Stock Price, News & Analysis → 41 banks launch ‘crypto dollar’ (From Stansberry Research) (Ad) Free CHTP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CHTP) alerts: Email Address Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). About (CHTP) Stock (NASDAQ:CHTP)Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. In addition, the Company is developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis and is exploring potential applications in multiple other autoimmune disorders.Read More Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). CHTP Stock News HeadlinesNovember 10, 2023 | finance.yahoo.comBrave Healer Productions Announces the Release of The Life-Changing Power of Self-LoveSeptember 20, 2023 | news.yahoo.comExeter Hospital recognized, York Hospital remains in Cigna network: Seacoast health newsJuly 23, 2023 | investing.comChelsea Therapeutics International (CHTP)June 8, 2023 | msn.comNickelback to play at Thompson-Boling ArenaJune 8, 2023 | msn.comCUBE-SHAPED croissant named the Crubik is the latest take on the croissantApril 8, 2023 | msn.comVIRAL: This college student was about to be late for class—until he saw his professor on the same trainApril 8, 2023 | msn.comVIRAL: This college student was about to be late in class—until he saw his professor on the same trainJanuary 11, 2023 | msn.comThe history of the Ranji Trophy’s female umpires Rathi, Narayanan, and VenugopalanNovember 27, 2022 | msn.comAlabama takes down No. 1 UNC in 4 OT thrillerNovember 1, 2022 | msn.comCapiz flood leaves councilor deadSeptember 8, 2022 | msn.comQueen Elizabeth Has Passed Away at 96June 30, 2022 | bbc.co.ukDiving finals: 10m MenJune 18, 2022 | benzinga.comToyota PriusSee More Headlines Receive CHTP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CHTP) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CHTP CUSIPN/A CIK1333763 Webwww.chelseatherapeutics.com Phone+1-704-3411516FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report CHTP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (CHTP) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CHTP) investors own include (AVNR) (AVNR), LadRx (CYTR), Dynavax Technologies (DVAX), Ariad Pharmaceuticals (ARIA), Avid Bioservices (CDMO), DryShips (DRYS), (GTATQ) (GTATQ), Intel (INTC), Plug Power (PLUG) and Rexahn Pharmaceuticals (REXN). This page (NASDAQ:CHTP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyDems have chosen Biden replacement?Paradigm Press41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford Club4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CHTP) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.